Phylogenetic analysis of influenza B hemagglutinin and neuraminidase gene in Binzhou City from 2013 to 2018
-
摘要:
目的 分析滨州市2013-2018监测年度B型流感病毒血凝素(hemagglutinin, HA)、神经氨酸酶(neuraminidase, NA)基因突变及其抗原变异特征。 方法 采集滨州市2013-2018年的流感监测哨点医院流感样病例(influenza-like illness, ILI)咽拭子标本进行病毒分离, 选取29株B型流感分离代表毒株进行HA、NA基因序列测定, 通过基因分析软件进行同源性比对、构建HA、NA基因进化树。 结果 2013-2018各年度B型流感占比分别为47.0%、23.0%、31.0%、7.2%和65.1%, 差异有统计学意义(χ2=1 485.143, P < 0.001)。2013-2014年度分离株与当年世界卫生组织推荐的疫苗株匹配度差。2013-2014年度流行的B型流感病毒为Yamagata系HA与Victoria系NA基因的重配株。 结论 2013-2018监测年度, 滨州市B型流感病毒的进化是通过系间基因重配、不同谱系共流行、连续不断的不同抗原谱系的更替来完成的。 Abstract:Objective To investigate the mutation of hemagglutinin(HA), neuraminidase(NA) gene and amino acid variation of influenza B. Methods Throat swab specimens were taken from patient with influenza-like illness(ILI) and were investigated for the influenza virus identification from 2013 to 2018, and 29 strains of influenza B viruses were selected. HA, NA gene sequencing of the viruses were performed and were aligned using molecular evolutionary genetics analysis software. The phylogenetic tree was constructed. Results During the influenza seasons from 2013 to 2018, the detection rates of influenza B virus were 47.0%, 23.0%, 31.0%, 7.2% and 65.1%, respectively. Statistically significant differences between the proportion of influenza B viruses were observed(χ2=1 485.143, P < 0.001). The isolates from 2013 to 2014 did not correspond to vaccine strain, which was recommended by world health organization for the influenza season. Conclusions The evolution of influenza B virus was achieved through interlineal gene recombination, co-prevalence of different lineages, and continuous replacement of different antigenic lineages in Binzhou from 2013 to 2018. -
Key words:
- Influenza B virus /
- Hemagglutinin /
- Neuraminidase /
- Variation /
- Sequence alignment
-
表 1 2013-2018年度滨州B型流感监测情况
Table 1. Influenza surveillance of B in Binzhou from 2013 to 2018
年度 监测标本数(例) 阳性数(例) 阳性率(%, 95% CI) B型Victoria系 B型Yamagata系 n(%) n(%) 2013-2014 903 115 12.7(10.5~14.9) 0(0.0) 54(47.0) 2014-2015 788 61 7.7(5.8~9.6) 0(0.0) 14(23.0) 2015-2016 773 126 16.3(13.7~18.9) 35(27.8) 4(3.2) 2016-2017 1 065 125 11.7(9.7~13.6) 9(7.2) 0(0.0) 2017-2018 1 239 338 27.3(24.8~29.8) 0(0.0) 220(65.1) 合计 4 768 765 16.0(15.0~16.9) 44(5.8) 292(38.2) -
RotB PA, Wallis TR, Harmon MW, et al. Cocirculation of two distinct evolutjonary lineages of influenza B virus since 1983[J]. Virology, 1990, 175(1): 59-68. DOI: 10.1016/0042-6822(90)90186-u. 焦鹏涛, 范文辉, 孙业平, 等. B型流感病毒研究进展[J].生物工程学报, 2018, 34(6): 821-831. DOI: 10.13345/j.cjb.180138.Jiao PT, Fan WH, Sun YP, et al. Research advance of influenza B viruses[J]. Chin J Biotechnol, 2018, 34(6): 821-831. DOI: 10.13345/j.cjb.180138. Caini S, Kusznierz G, Garate VV, et al. The epidemiological signature of influenza B virus and its B/Victoria and B/Yamagata lineages in the 21st century[J]. PLoS One, 2019, 14(9): e0222381. DOI: 10.1371/journal.pone.0222381. 中国疾病预防控制中心.全国流感监测技术指南(2017版)[S].北京, 2017.China Center for Disease control and Prevention. Technical guidelines for national influenza surveillance(2017 edition)[S]. Beijing, 2017. 刘书珍, 权娅茹, 邵铭, 等.乙型流感病毒疫苗株全基因组序列测定及其在疫苗质量控制中的应用[J].中国生物制品学杂志, 2019, 32(4): 369-374. DOI: 10.13200/j.cnki.cjb.002555.Liu SZ, Quan YR, Shao M, et al. Whole genome sequencing of influenza virus B and its application in vaccine quality control[J]. Chin J Biologicals, 2019, 32(4): 369-374. DOI: 10.13200/j.cnki.cjb.002555. Wang Q, Cheng F, Lu M, et al. Crystal structure of unligan-ded influenza B virus hemagglutinin[J]. J Virol, 2008, 82(6): 3011-3020. DOI: 10.1128/JVI.02477-07. Lin YP, Gregory V, Bennett M, et al. Recent changes among human influenza viruses[J]. Virus Res, 2004, 103(1-2): 47-52. DOI: 10.1016/j.virusres.2004.02.011. Tsedenbal N, Tsend-Ayush A, Badarch D, et al. Influenza B viruses circulated during last 5 years in Mongolia[J]. PLoS One, 2018, 13(11): e0206987. DOI: 10.1371/journal.pone.0206987. Koutsakos M, Nguyen TH, Barclay WS, et al. Knowns and unknowns of influenza B viruses[J]. Future Microbiol, 2016, 11(1): 119-135. DOI: 10.2217/fmb.15.120. Burnham AJ, Armstrong J, Lowen AC, et al. Competitive fitness of influenza B viruses with neuraminidase inhibitor-resistant substitutions in a coinfection model of the human airway epithelium[J]. Virol, 2015, 89(8): 4575-4587. DOI: 10.1128/JVI.02473-14. Gubareva LV, Besselaar TG, Daniels RS, et al. Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2015-2016[J]. Antiviral Res, 2017, 146(10): 12-20. DOI: 10.1016/j.antiviral.2017.08.004. Chen R, Holmes EC. The evolutionary dynamics of human influenza B virus[J]. J Mol Evol, 2008, 66(6): 655-663. DOI: 10.1007/s00239-008-9119-z. 成艳辉, 王钊, 肖宁. 2013-2014年中国B型流感病毒抗原性及基因特性分析[J].中华实验和临床病毒学杂志, 2015, 29(5): 385-390. DOI: 10.3760/cma.j.issn.1003-9279.2015.05.001.Cheng YH, Wang Z, Xiao N. Antigenic and genetic characteristics of influenza B virus in the mainland of China 2013-2014[J]. Chinese J Exp Clin Virol, 2015, 29(5): 385-390. DOI: 10.3760/cma.j.issn.1003-9279.2015.05.001. 焦素黎, 胡逢蛟, 张姝, 等. 2003-2014年浙江省宁波市乙型流行性感冒病毒血凝素和神经氨酸酶基因变化特征分析[J].疾病监测, 2015, 30(6): 448-453. DOI: 10.3784/j.issn.1003-9961.2015.06.005.Jiao SL, Hu FJ, Zhang S, et al. Mutation of hemagglutinin and neuraminidase genes of influenza B virus isolated in Ningbo, Zhejiang, 2003-2014[J]. Disease Surveillance, 2015, 30(6): 448-453. DOI: 10.3784/j.issn.1003-9961.2015.06.005. 曾晓旭, 王大燕, 舒跃龙. B型流行性感冒病毒基因进化研究进展[J].中华预防医学杂志, 2013, 47(7): 656-658. DOI: 10.3760/cma.j.issn.0253-9624.2013.07.017.Zeng XX, Wang DY, Shu YL. Research advance of influenza B viruses genetic evolution[J]. Chin J Prev Med, 2013, 47(7): 656-658. DOI: 10.3760/cma.j.issn.0253-9624.2013.07.017. -